How Much Weight Can You Lose On Mounjaro In A Month? - Guide | Cured Pharmacy

How Much Weight Can You Lose On Mounjaro In A Month?

WEIGHT LOSS · 22 MIN READ
Written by Cured Pharmacy
Published on 18 August 2026
★★★★★ Judge.me Reviews
Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

Featured Product

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

From£145.00£124.99 UK-based prescribers · Discreet delivery · Free private prescription
Start Assessment → ✓ Lowest price guarantee
DISCOUNT CODE: FIRST20

£20 off for new patients

Tarun Kumar, Prescribing Pharmacist at Cured Pharmacy

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 18 August 2026

If you have recently started Mounjaro or are seriously considering it, the very first question in your head is almost certainly this: how much weight can I realistically expect to lose, and how quickly will it happen? You have probably scrolled through before and after photos, read a handful of forum threads, and come away more confused than when you started. Some people claim they dropped two stone in six weeks; others say they barely noticed a difference in the first month. The truth, as with most things in medicine, sits somewhere more nuanced — and it is actually far more encouraging than the sceptics suggest. This article breaks down exactly what the clinical evidence says, what real patients in the UK experience month by month, and what you can do right now to make your first month count.

Summary

Mounjaro (tirzepatide) is currently one of the most effective licensed weight loss treatments available in the UK. Most people lose between 2 and 6 pounds in their very first month, with results accelerating significantly from month three onwards as doses increase.

  • Average first-month weight loss on Mounjaro is roughly 2 to 6 lb (approximately 1 to 2.7 kg) at the starting 2.5 mg dose.
  • By month three, many patients report losses of 10 to 15 lb as doses escalate.
  • Clinical trials show up to 20.9% total body weight loss over 72 weeks on the highest dose.
  • Results vary based on diet, activity, metabolic health, and how consistently injections are taken.
  • Cured Pharmacy offers Mounjaro with free private prescriptions, UK-based prescribers, and discreet delivery — use code FIRST20 for £20 off as a new patient.

Table of Contents

  1. What to Expect Month by Month on Mounjaro
  2. Monthly Weight Loss Estimator Tool
  3. Factors That Affect How Much Weight You Lose
  4. What the Clinical Trials Actually Say
  5. How to Maximise Your Results in Month One
  6. Why Patients Choose Cured Pharmacy for Mounjaro
  7. Mounjaro Weight Loss by Dose and Month: Data Overview
  8. Key Takeaways
  9. When to Seek Professional Advice
  10. Scientific References
  11. FAQs

How Much Weight Can You Lose on Mounjaro in a Month? A Realistic Timeline

The honest answer is that your first month on Mounjaro will likely feel underwhelming compared to what comes later — and that is completely normal. The medication starts at 2.5 mg weekly, which is a tolerability dose rather than a full therapeutic dose. At this stage, tirzepatide is essentially introducing itself to your body, stimulating GIP and GLP-1 receptors simultaneously to begin curbing appetite and improving insulin sensitivity. Most people notice reduced hunger within the first two weeks, but the scale may not move dramatically yet.

Based on data from the SURMOUNT-1 trial and clinical experience across UK weight management services, here is a realistic month by month picture for someone who starts Mounjaro with consistent lifestyle changes:

  • Month 1 (2.5 mg dose): 1 to 3 kg (roughly 2 to 6 lb) — appetite reduction begins, scale starts moving.
  • Month 2 (5 mg dose): An additional 2 to 4 kg — appetite suppression strengthens noticeably.
  • Month 3 (7.5 mg dose): Cumulative loss of 6 to 10 kg for many patients — this is often when people really start to see visible changes.
  • Months 4 to 6: Continued losses toward 10 to 15% of starting body weight for a significant proportion of users.
  • Months 6 to 18: Full clinical benefit realised — average of 15 to 21% body weight reduction on 15 mg.

It is worth noting that how much weight can you lose on Mounjaro in a month is not a fixed figure — it is a sliding scale that improves with every dose escalation step. People who feel frustrated after week four should hold steady, because month two and three are where the treatment genuinely begins to transform results. If you are exploring weight loss treatment options in the UK, understanding this timeline in advance removes a huge amount of anxiety.

Monthly Weight Loss Estimator

Mounjaro Monthly Weight Loss Estimator

Enter your details below to see an estimated monthly weight loss range based on clinical trial data. This is a guide only — individual results vary.

Based on SURMOUNT-1 trial data. For clinical guidance, consult your prescriber.

Factors That Affect How Much Weight You Lose on Mounjaro Each Month

No two people respond to tirzepatide in exactly the same way, and understanding why that is the case can help you manage expectations and take practical steps to improve your personal results. When patients ask how much weight can you lose on Mounjaro in a month, the answer is shaped by several interconnected variables that go well beyond simply taking the injection each week.

Starting Body Weight and BMI

People with a higher starting BMI tend to see larger absolute numbers on the scale in early months, simply because there is more metabolically active tissue to work with. Someone starting at 130 kg may lose 3 to 4 kg in month one, while someone at 95 kg might lose 1.5 to 2.5 kg. Both represent a similar percentage of body weight, which is the more clinically meaningful measure.

Diet Quality During Treatment

Mounjaro dramatically reduces appetite — but if you fill a smaller stomach with highly processed, calorie-dense food, your results will reflect that. Patients who adopt even a moderate reduction in ultra-processed food and increase protein and vegetables see meaningfully better monthly losses. You do not need a rigid diet plan; you just need to work with the appetite suppression rather than against it.

Dose Level

This is probably the biggest single variable. Monthly weight loss at 2.5 mg is genuinely modest. Monthly loss at 10 to 15 mg is where the treatment truly earns its reputation. Many patients on the NHS or through private clinics in 2026 are now staying at 5 mg or 7.5 mg for longer to manage tolerability, which affects the speed of results without affecting ultimate outcomes.

Metabolic Health and Comorbidities

People with insulin resistance, type 2 diabetes, or polycystic ovary syndrome may find that tirzepatide's dual GIP and GLP-1 action is particularly powerful for them, as the medication directly addresses the metabolic dysfunction driving their weight gain. Weight loss treatments like Mounjaro work especially well in these populations over sustained periods.

  • Age, sex, and hormonal status all influence monthly loss rates.
  • Physical activity amplifies fat loss while preserving lean muscle — important for long-term metabolic rate.
  • Sleep quality and stress levels affect cortisol, which directly opposes weight loss.
  • Consistency with weekly injections is non-negotiable — missing doses interrupts the continuous hormonal signalling that drives appetite reduction.

What the Clinical Trials Actually Say About Monthly Mounjaro Weight Loss

The SURMOUNT-1 trial is the landmark study behind Mounjaro's weight loss licence. Published in the New England Journal of Medicine in 2022, it followed 2,539 adults with obesity or overweight (without type 2 diabetes) over 72 weeks. The results were genuinely historic — participants on tirzepatide 15 mg lost an average of 20.9% of their body weight, compared to 3.1% on placebo. To put that in concrete terms: someone starting at 100 kg could expect to weigh around 79 kg at the end of treatment.

Breaking those results down by month gives a clearer picture of the trajectory. Participants in the 15 mg group lost approximately 5% of body weight by week 12 (roughly month three), 10% by around week 24 (month six), and continued losing through to weeks 60 to 72. The important implication here is that the first month, while meaningful, is the smallest slice of a much larger and more impressive story.

The SURMOUNT-2 trial, which focused on patients with type 2 diabetes, showed slightly lower but still impressive results — around 15.7% body weight loss at 72 weeks on 15 mg. This reflects the well-established phenomenon that diabetes medications can blunt weight loss responses slightly compared to non-diabetic populations. Even so, 15.7% represents a profound therapeutic outcome by any clinical standard.

  • SURMOUNT-1: 20.9% body weight loss at 72 weeks on 15 mg tirzepatide.
  • Approximately 1 in 3 participants achieved 25% or more total body weight loss.
  • Early responders (those losing 5% or more by week 12) tended to achieve the highest ultimate losses.
  • Discontinuation due to side effects occurred in around 4.3% of patients — primarily gastrointestinal.
  • These results far exceed those seen with older GLP-1 monotherapies like liraglutide and are broadly comparable to bariatric surgery outcomes in some patient groups.

For patients accessing alternative injectable weight loss treatments such as Wegovy (semaglutide), it is worth knowing that head-to-head comparisons consistently favour tirzepatide for total weight loss, making Mounjaro the stronger clinical choice for most eligible patients in 2026.

How to Maximise Your Weight Loss Results in Month One

Month one on Mounjaro sets the foundation. Even if the numbers on the scale are modest, what you do during these first four weeks determines how successfully the medication integrates into your lifestyle going forward. Patients who use this initial period wisely tend to see dramatically better outcomes at three, six, and twelve months.

Prioritise Protein at Every Meal

Protein is the macronutrient that works best alongside tirzepatide's appetite suppression. It preserves muscle mass during caloric restriction and keeps you fuller for longer between doses. Aim for at least 1.2 to 1.6 g of protein per kg of body weight per day. Greek yoghurt, eggs, chicken, fish, legumes, and cottage cheese are all practical, affordable UK staples that fit this approach brilliantly.

Track Your Injection Days Strictly

Missing even a single weekly injection breaks the continuous receptor stimulation that underpins appetite control. Set a recurring calendar reminder, keep the pen in a consistent place, and treat your injection day as non-negotiable. Cured Pharmacy's dispensing schedule is designed to ensure you always have your next pen ready before the current one runs out — removing one of the most common causes of accidental gaps in treatment.

Reduce Ultra-Processed Food Gradually

You do not need to overhaul everything at once. Research from the University of Cambridge shows that even a moderate reduction in ultra-processed food consumption correlates with significantly better weight loss outcomes when combined with GLP-1 or GIP/GLP-1 receptor agonists. Swap two or three UPF meals per week for whole food alternatives and let Mounjaro's appetite suppression do the rest.

Gentle Movement Matters More Than You Think

You do not need to join a gym in week one. Daily walking — 7,000 to 10,000 steps — has been shown to meaningfully accelerate fat loss when combined with appetite-reducing medications. It also helps manage the mild nausea some patients experience, as light movement aids gastric emptying. Support your joints and overall wellbeing during this period by maintaining good nutritional basics — Vitamin D3 supplements are particularly important during UK winters when many patients are deficient.

  • Stay well hydrated — at least 2 litres of water daily supports metabolic function and reduces nausea side effects.
  • Eat slowly — tirzepatide slows gastric emptying, and eating too fast can trigger nausea and discomfort.
  • Avoid alcohol in the first month — it adds empty calories and can worsen nausea at the 2.5 mg dose.
  • Keep a simple food journal for the first four weeks — patients who track tend to lose 20 to 30% more weight according to multiple behavioural studies.

Why Patients Across the UK Choose Cured Pharmacy for Their Mounjaro Treatment

When you are committing to a weight loss treatment that may run for twelve months or more, the pharmacy you choose matters enormously. Cured Pharmacy has built a reputation in the UK weight management space for combining clinical rigour with genuinely patient-centred service, and the difference is noticeable from the very first interaction.

All prescriptions at Cured Pharmacy are issued by UK-registered prescribers following a thorough online consultation. There are no shortcuts here — your safety and eligibility are assessed properly, and the process is both MHRA-compliant and CQC-aligned. The private prescription is provided free of charge, which saves you a meaningful amount compared to some providers who charge separately for the consultation and the prescription. Discreet, temperature-controlled delivery ensures your Mounjaro KwikPen arrives in perfect condition, ready to use.

For new patients, the discount code FIRST20 takes £20 off your first order — a practical saving that makes starting your treatment even more accessible. The pricing is genuinely competitive, and the lowest price guarantee means you are not overpaying for a medication that, frankly, you will be taking consistently and do not want to find cheaper elsewhere mid-treatment only to lose continuity of care.

Compared to some online services where patients report inconsistent stock, slow response times, or difficulty escalating their dose on schedule, Cured Pharmacy maintains a reliable supply chain and clinical oversight that keeps your treatment progressing as planned. This consistency is not just a convenience — it directly affects how much weight can you lose on Mounjaro in a month, because uninterrupted treatment is the single most important variable within your control. If you are also curious about how Mounjaro compares to Wegovy semaglutide injections, the Cured team can guide you through the clinical differences to help you choose the right option for your health profile.

  • Free private prescription included with every Mounjaro order.
  • UK-registered prescribers conducting thorough safety assessments.
  • Discreet, temperature-controlled delivery to your door.
  • Lowest price guarantee on Mounjaro pens.
  • Use discount code FIRST20 for £20 off your first order as a new patient.

Mounjaro Weight Loss by Dose and Month: Clinical Data Overview

Month of Treatment Typical Dose Estimated Monthly Loss (kg) Cumulative Average Loss (%) Key Experience
Month 1 2.5 mg 1 to 2.7 kg ~2 to 3% Appetite begins to reduce; scale moves slowly but consistently
Month 2 5 mg 2 to 3.5 kg ~4 to 6% Stronger satiety; food noise noticeably quieter for most patients
Month 3 7.5 mg 2.5 to 4.5 kg ~7 to 10% Visible body changes; energy often improves; major motivation boost
Month 4 10 mg 2.5 to 4.5 kg ~10 to 13% Blood pressure and blood sugar improvements often recorded at this stage
Month 5 12.5 mg 2.5 to 5 kg ~13 to 16% Consistent fat loss; some patients plateau briefly before continuing
Month 6+ 15 mg 2.5 to 5.5 kg ~16 to 21% Maximum therapeutic effect; SURMOUNT-1 peak results at 72 weeks

These figures are derived from the SURMOUNT-1 and SURMOUNT-2 trial data and reflect population averages. Individual outcomes will vary. Some patients experience faster escalation and higher monthly losses; others find that staying at a lower dose for longer provides better tolerability while still delivering excellent six-month outcomes. Supporting your body during this process with adequate micronutrients is wise — many patients on calorie-restricted diets benefit from comprehensive multivitamin support to fill nutritional gaps that can emerge during significant weight loss.

Key Takeaways

  • Most patients lose 1 to 2.7 kg in their first month on Mounjaro at the 2.5 mg starting dose — results accelerate substantially as doses increase over the following months.
  • The SURMOUNT-1 trial demonstrated average total body weight loss of 20.9% over 72 weeks at the highest dose of 15 mg, making Mounjaro one of the most effective pharmaceutical weight loss options available in 2026.
  • Diet quality, dose level, consistency of injections, and metabolic health are the four most significant factors determining your monthly loss rate.
  • Cured Pharmacy offers Mounjaro with a free private prescription, UK-based clinical oversight, discreet delivery, and a lowest price guarantee — new patients save £20 with discount code FIRST20.
  • Month one is about establishing the habit and tolerating the medication well — the most impressive and life-changing results come from months three to six and beyond.

When to Seek Professional Advice

Mounjaro is a prescription-only medication for a reason. While it is very well tolerated by the majority of patients, there are circumstances where you should contact your prescriber or a healthcare professional promptly rather than waiting for your next scheduled review.

  • Severe or persistent vomiting that prevents you from eating or drinking adequately — dehydration is a real risk on higher doses.
  • Sudden, severe abdominal pain that radiates to the back — this warrants urgent assessment to rule out pancreatitis, a rare but recognised risk.
  • Signs of hypoglycaemia (shaking, sweating, confusion) — particularly relevant if you are also taking insulin or sulphonylureas for type 2 diabetes.
  • Changes in vision or unexplained eye symptoms — reported rarely with GLP-1 class medications and worth flagging early.
  • No weight loss at all after eight weeks of consistent use at 5 mg or above — this may indicate a need to review your approach or consider whether an alternative treatment is more appropriate for you.
  • Any symptoms that feel unusual or concern you — always default to contacting your prescriber. Cured Pharmacy's clinical team is accessible and responsive, removing the barrier that sometimes stops patients from speaking up when they should.

For broader support on your weight management journey, explore the full range of weight loss treatments available through Cured Pharmacy, where clinically supervised options are matched to your individual health profile.

Scientific References

  1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022. [Accessed 18 August 2026]
  2. Garvey WT et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). New England Journal of Medicine, 2023. [Accessed 18 August 2026]
  3. NICE Technology Appraisal TA1026: Tirzepatide for managing overweight and obesity. NICE, 2024. [Accessed 18 August 2026]
  4. Mounjaro (tirzepatide) Summary of Product Characteristics. Electronic Medicines Compendium (EMC), 2023. [Accessed 18 August 2026]
  5. MHRA: Mounjaro (tirzepatide) approved for weight management in adults. MHRA, 2023. [Accessed 18 August 2026]
  6. NHS: Tirzepatide (Mounjaro) patient information. NHS, 2024. [Accessed 18 August 2026]
  7. Del Prato S et al. Tirzepatide versus insulin degludec in type 2 diabetes. The Lancet Diabetes & Endocrinology, 2023. [Accessed 18 August 2026]
  8. Wilding JPH et al. GLP-1 and dual GIP/GLP-1 receptor agonists for obesity treatment. BMJ, 2023. [Accessed 18 August 2026]
  9. Diabetes UK: NICE approves tirzepatide (Mounjaro) for obesity management. Diabetes UK, 2024. [Accessed 18 August 2026]
  10. Coskun T et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. Nature Medicine, 2022. [Accessed 18 August 2026]
  11. Frías JP et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. The Lancet, 2021. [Accessed 18 August 2026]
  12. British National Formulary (BNF): Tirzepatide. NICE/BNF, 2024. [Accessed 18 August 2026]
  13. Royal College of Physicians: Clinical guidance on obesity pharmacotherapy. RCP, 2023. [Accessed 18 August 2026]
  14. Husain M et al. Cardiovascular outcomes with tirzepatide: emerging evidence. eClinicalMedicine, The Lancet, 2023. [Accessed 18 August 2026]
  15. Rauber F et al. Ultra-processed food consumption and excess weight among UK adults. Proceedings of the Nutrition Society, Cambridge University Press, 2021. [Accessed 18 August 2026]

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today.

Once you complete a short online assessment, you will be able to choose your preferred treatment and quantity from a list of safe, medically approved options tailored to you.

Start My AssessmentReturning Customer?Log In to Your Account

Frequently Asked Questions

How much weight can you realistically lose on Mounjaro in the first month?

How much weight you can realistically lose on Mounjaro in the first month is typically between 1 and 2.7 kg (roughly 2 to 6 lb) at the starting 2.5 mg dose. This reflects the tolerability phase of treatment. Results increase substantially from month two onward as the dose escalates toward the full therapeutic range of 10 to 15 mg weekly.

Is Mounjaro safe to use long-term for weight loss in the UK?

Mounjaro is safe for long-term weight loss in the UK when prescribed appropriately by a registered prescriber. It is MHRA-approved and NICE-recommended for chronic weight management. The SURMOUNT-1 trial monitored patients safely for 72 weeks, and ongoing cardiovascular outcome trials in 2026 continue to support its favourable long-term safety profile in eligible adults.

Can you take Mounjaro with other medications for weight loss or diabetes?

Whether you can take Mounjaro with other medications depends on your specific prescriptions. Mounjaro should not generally be combined with other GLP-1 receptor agonists such as semaglutide. Caution is required alongside insulin and sulphonylureas due to hypoglycaemia risk. Always disclose your full medication list to your prescriber at Cured Pharmacy before starting treatment to ensure safe co-prescribing.

What is the starting dose of Mounjaro and how does it escalate?

The starting dose of Mounjaro is 2.5 mg once weekly for the first four weeks. It is then escalated in 2.5 mg increments every four weeks — to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg — based on tolerability and clinical response. The escalation schedule is designed to minimise gastrointestinal side effects while progressively increasing therapeutic effect.

Back to blog